Literature DB >> 32304040

The Use of Metformin to Increase the Human Healthspan.

Veronika Piskovatska1, Kenneth B Storey2, Alexander M Vaiserman3, Oleh Lushchak4.   

Abstract

Metformin is a safe, effective and useful drug for glucose management in patients with diabetes. However in recent years, more attention has been paid to the possibility of using metformin as an anti-aging drug. It was shown to significantly increase the lifespan in some model organisms and delay the onset of age-associated declines. The current review summarizes advances in clinical research on the potential role of metformin in the field of lifespan and healthspan extension. Growing amounts of evidence from clinical trials suggest that metformin can effectively reduce the risk of many age-related diseases and conditions, including cardiometabolic disorders, neurodegeneration, chronic inflammation and frailty. Metformin also holds promise as a drug that could be repurposed for chemoprevention or adjuvant therapy for certain types of cancer. Moreover, metformin induces autophagy by activation of AMPK and can thus be potentially used to promote heathspan by hormesis-like mechanisms. Although long-term intake of metformin is associated with low risk of adverse events, well-designed clinical trials are still required to uncover the potential use of this drug as a geroprotector.

Entities:  

Keywords:  Cancer; Healthspan; Longevity; Metformin; Off-label prescription; Safety

Mesh:

Substances:

Year:  2020        PMID: 32304040     DOI: 10.1007/978-3-030-42667-5_13

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  9 in total

Review 1.  Metformin for Cardiovascular Protection, Inflammatory Bowel Disease, Osteoporosis, Periodontitis, Polycystic Ovarian Syndrome, Neurodegeneration, Cancer, Inflammation and Senescence: What Is Next?

Authors:  Moein Ala; Mahan Ala
Journal:  ACS Pharmacol Transl Sci       Date:  2021-11-01

Review 2.  Senescence mechanisms and targets in the heart.

Authors:  Maggie S Chen; Richard T Lee; Jessica C Garbern
Journal:  Cardiovasc Res       Date:  2022-03-25       Impact factor: 10.787

Review 3.  Autophagy and the hallmarks of aging.

Authors:  Susmita Kaushik; Inmaculada Tasset; Esperanza Arias; Olatz Pampliega; Esther Wong; Marta Martinez-Vicente; Ana Maria Cuervo
Journal:  Ageing Res Rev       Date:  2021-09-24       Impact factor: 10.895

Review 4.  Cellular Senescence Affects Cardiac Regeneration and Repair in Ischemic Heart Disease.

Authors:  Chi Yan; Zhimeng Xu; Weiqiang Huang
Journal:  Aging Dis       Date:  2021-04-01       Impact factor: 6.745

5.  Mitochondrial dysfunction in mandibular hypoplasia, deafness and progeroid features with concomitant lipodystrophy (MDPL) patients.

Authors:  Michela Murdocca; Paola Spitalieri; Angela Cappello; Fiorella Colasuonno; Sandra Moreno; Eleonora Candi; Maria Rosaria D'Apice; Giuseppe Novelli; Federica Sangiuolo
Journal:  Aging (Albany NY)       Date:  2022-02-23       Impact factor: 5.682

Review 6.  Nanoparticles-based anti-aging treatment of Alzheimer's disease.

Authors:  Jian-Jian Chu; Wen-Bo Ji; Jian-Hua Zhuang; Bao-Feng Gong; Xiao-Han Chen; Wen-Bin Cheng; Wen-Danqi Liang; Gen-Ru Li; Jie Gao; You Yin
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

Review 7.  Beneficial Effects of Metformin on the Central Nervous System, with a Focus on Epilepsy and Lafora Disease.

Authors:  Pascual Sanz; José Maria Serratosa; Marina P Sánchez
Journal:  Int J Mol Sci       Date:  2021-05-19       Impact factor: 5.923

8.  Metformin Inhibits the Development of Hypopharyngeal Squamous Cell Carcinoma through Circ_0003214-Mediated MiR-489-3p-ADAM10 Pathway.

Authors:  Xiaoqiang Chen; Chen Li; Wei Chen; Shuchun Lin; Xuehan Yi; Qin Lin; Hao Xu; Desheng Wang
Journal:  J Oncol       Date:  2021-07-13       Impact factor: 4.375

9.  Reasons for Exclusion of Apparently Healthy Mature Adult and Senior Dogs From a Clinical Trial.

Authors:  Nicole H Gibbs; Hannah Michalski; Daniel E L Promislow; Matt Kaeberlein; Kate E Creevy
Journal:  Front Vet Sci       Date:  2021-06-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.